Preclinical data with the investigational gene therapy INS1202 show improvements in survival and motor performance in ALS.

SATURDAY, March 8, 2025 (HealthDay News) -- Cardiovascular disease is a general term that refers to many different types of heart problems. Heart disease is the No. 1 cause of death in the United ...

Amyotrophic lateral sclerosis is a slow moving disease leading to paralysis and inability to breathe. But the EverythingALS Pathfinders App connects over 7,000 to share information and experiences ...

Chronic kidney disease (CKD) refers to gradual kidney damage that reduces the kidneys’ ability to filter blood. CKD progresses through stages 1 to 5. Stage 4 CKD is the final stage before ...

MND Scotland says that around 450 people in the country are living with Motor Neurone Disease. One symptom that can easily be brushed off as normal is excessive saliva, or drooling. MND is difficult ...

This is expected to lower levels of the toxic protein, slowing disease progression in this patient group. “Qalsody is the first therapy to directly target the root cause of SOD1-ALS, addressing the ...

People are being warned to keep an eye on signs and symptoms that could point to a disease which ... during the early stages of the condition. Amyotrophic lateral sclerosis (ALS) is the most ...

People are being urged to watch for symptoms that may indicate Motor Neurone Disease (MND ... during the early stages of the condition. Amyotrophic lateral sclerosis (ALS) is the most common ...

One challenge in developing effective therapies has been the difficulty in objectively measuring disease progression and treatment response ... The study also confirmed that patients with bulbar-onset ...

NEW research has shown that tetramethylpyrazine nitrone is safe for patients with amyotrophic lateral sclerosis (ALS ... disease progression, showing an improvement of 3.63 kg (95% CI, 0.84-6.41 kg).